Unninayar Kamalam 4
4 · TETRAPHASE PHARMACEUTICALS INC · Filed Nov 15, 2017
Insider Transaction Report
Form 4
Unninayar Kamalam
Chief Financial Officer
Transactions
- Award
Employee Stock Option (Right to Buy)
2017-11-15+190,000→ 190,000 totalExercise: $6.07Exp: 2027-11-14→ Common Stock (190,000 underlying)
Footnotes (1)
- [F1]This option vests over four years. Twenty-five percent (25%) of the shares will vest on November 15, 2018 and 6.25% of the shares will vest at the end of each successive three month period thereafter.